ZymoGenetics Inc. v. Bristol-Myers Squibb Co.
1:06-cv-00500
Overview
Parties
Defendant
Bristol-Myers Squibb Co. Operating Company
Represented By
10 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
ZymoGenetics Inc. Operating Company
Represented By
6 Attorneys ListedKramer Levin Naftalis & Frankel LLP
990 March Road, Menlo Park, CA 94025
Kramer Levin Naftalis & Frankel LLP
990 Marsh Road, Menlo Park, CA 94025
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,843,725 A Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 14,687,788 A | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 89,100,787 A | European Counterpart (EP) | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 325,224 B1 | European Counterpart (EP) | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 8,910,087 | European Counterpart (EP) | View Official Patent → |
| 🇺🇸 United States | US 5,155,027 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 63,451,090 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 5,567,584 A | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5843725
Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
|
Filed: 1995-06-07
Issued: 1998-12-01
|
Expired (Term Ended)
Expires: 2015-06-07
|
|
|
US6018026
Biologically active dimerized and multimerized polypeptide fusions
|
Filed: 1997-11-26
Issued: 2000-01-25
|
Expired (Term Ended)
Expires: 2017-11-26
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
107
Dispositive
71
Granted
0
Denied
1
Pending / Review
106
Motions by Category
Key Dispositive Motions & Rulings